abstract |
The present invention relates to new compounds, which are derivatives of oxadiazole of the formula IB, in which P and Q are defined in the description. The compounds of the invention are useful in preventing or treating disorders of the central or peripheral nervous system, as well as other disorders regulated by mGluR5 receptors. |